Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Whitnell Jeffrey A
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
Avg. Two Year Performance
No purchase track record
80%
Avg. Sale Return
34%
Compound
1 Mo
3 Mo
6 Mo
1 Yr
2 Yr
Average Purchase Return
--
--
--
--
--
Purchase Success Rate
--
--
--
--
--
Average Sale Return
2%
4%
37%
70%
80%
Sale Success Rate
1 of 1
1 of 1
1 of 1
1 of 1
1 of 1
Akorn Inc.
Drugs
» Diagnostic Substances
Interim CEO/CFO:
Holdings:
62.77K
shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--
Elite Pharmaceuticals Inc.
Drugs
» Drug Manufacturers - Other
Director:
Holdings:
3.19M
shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--